The global FluoroSpot Industry is witnessing a transformative phase in 2026, driven by the increasing demand for high-sensitivity, multiplexed immune monitoring tools. As a sophisticated evolution of the traditional ELISpot, FluoroSpot technology allows researchers and clinicians to detect multiple cytokines or antibodies secreted by a single cell simultaneously. According to recent...